SNHG3 was previously found to exert oncogenic roles in a plethora of cancers: Based on current studies, SNHG3 was involved in TGF-β, NOTCH, JAK2/STAT3 and HGF pathway to promote cancer cell proliferation, invasion and inhibit apoptosis rate [12–14]. The gene discussed is JAK2; the disease is cancer.